Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion / Tanja Veselinović en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 214-220 Título : Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion Tipo de documento: texto impreso Autores: Tanja Veselinović, Autor ; Holger Schorn, Autor ; Ingo B. Vernaleken, Autor Fecha de publicación: 2022 Artículo en la página: pp. 214-220 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Prolactina, Hiperprolactinemia, Antipsicóticos, Reserpina, Aripiprazol Resumen: Antipsychotics are the most common cause of pharmacologically induced hyperprolactinemia. Although this adverse effect was the subject of numerous observations, the mechanisms and promotive factors were not completely investigated yet. Increased awareness of clinical consequences of hyperprolactinemia implicates the necessity for further examinations. Link: ./index.php?lvl=notice_display&id=29399 [artículo] Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion [texto impreso] / Tanja Veselinović, Autor ; Holger Schorn, Autor ; Ingo B. Vernaleken, Autor . - 2022 . - pp. 214-220. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 214-220 Palabras clave: Prolactina, Hiperprolactinemia, Antipsicóticos, Reserpina, Aripiprazol Resumen: Antipsychotics are the most common cause of pharmacologically induced hyperprolactinemia. Although this adverse effect was the subject of numerous observations, the mechanisms and promotive factors were not completely investigated yet. Increased awareness of clinical consequences of hyperprolactinemia implicates the necessity for further examinations. Link: ./index.php?lvl=notice_display&id=29399

---

1 (1 - 1 / 1)